#United States #Natus Medical #Middleton #EEG Advisory Board #EMG Advisory Board

Natus Medical's Global Advisory Boards: A New Era in Neurodiagnostics

Natus Medical Incorporated, renowned for its excellence in neurodiagnostic solutions, has made a significant leap in clinical collaboration. The company successfully held its inaugural Global EMG Advisory Board and its first EEG Advisory Board meeting for Europe and Asia Pacific. Conducted from November 4 to 6 at their Italian headquarters in Mogliano Veneto, these meetings brought together esteemed experts from the Americas, Europe, and the Asia-Pacific region.

Strategic Collaboration with Leading Clinicians

The gatherings included top neurologists, neurophysiologists, epileptologists, and specialists in neuromuscular disorders. They aimed to offer strategic insights into the evolving landscape of clinical needs and technological advancements, fostering better patient care. Holly Lorigan, DO, Chair of the Global EMG Advisory Board and Division Head at Henry Ford Health, emphasized the importance of clinician partnerships in steering the future of neurodiagnostics.

Strengthening Innovation and Product Development

Natus’s commitment to advancing neurodiagnostics is evident in its establishment of these boards. Following the launch of its Global EEG Advisory Board earlier in May, Natus is deepening its engagement with the international clinical community. This initiative ensures that their innovation strategy and product development align with the needs of healthcare professionals and the patients they serve.

Chris Landon, CEO of Natus, articulated that as leaders in neurodiagnostics, it is their responsibility to guide the future of neurological care. The assembly of global clinicians provides broader insights beyond specific technologies, helping to understand the changing requirements of patients and healthcare systems. The formation of these advisory boards reinforces Natus's commitment to integrating clinical expertise into their innovation strategy.

Key Milestones and Future Directions

The Global EMG Advisory Board represents a crucial step in enhancing electrodiagnostic medicine and fostering collaboration within the neuromuscular community. Chaired by Dr. Holly Lorigan, the board includes recognized authority figures in EMG, nerve conduction studies, neuromuscular ultrasound, and clinical neurophysiology.

Simultaneously, the EMEA/APAC EEG Advisory Board convened to bring diverse international perspectives into the fold. Experts specializing in epilepsy, neurocritical care, and advanced EEG technologies collaborated to identify ongoing challenges and opportunities affecting EEG practices globally.

The comprehensive expertise gathered from both the EMG and EEG boards will inform Natus’s strategic priorities. These include enhancing product development, strengthening clinical evidence generation, optimizing workflows, and enriching global medical education programs.

Notable Members of the Advisory Boards

Global EMG Advisory Board:

• - Dr. Jacquie Deeb: Barking, Havering, and Redbridge University Hospitals NHS Trust, United Kingdom
• - Dr. Leena Lauronen: HUS Helsinki University Hospital and University of Helsinki, Finland
• - Dr. Holly Lorigan: Henry Ford Health, United States
• - Dr. Kristian Bernhard Nilsen: Oslo University Hospital and University of Oslo, Norway
• - Dr. David Preston: University Hospitals Cleveland Medical Center and Case Western Reserve University, United States
• - Dr. Hatice Tankisi: Aarhus University Hospital and Aarhus University, Denmark

EMEA/APAC EEG Advisory Board:

• - Dr. Michael Fong: Westmead Hospital and University of Sydney, Australia
• - Dr. Philippe Kahane: Grenoble Alpes University Hospital and Université Grenoble Alpes, France
• - Dr. Kheng-Seang Lim: Universiti Malaya, Malaysia
• - Dr. Brian Litt: University of Pennsylvania, United States
• - Dr. Stefano Meletti: University Hospital of Parma and University of Parma, Italy
• - Dr. Ronit Pressler: Great Ormond Street Hospital for Children and University College London, United Kingdom
• - Dr. Philippe Ryvlin: Lausanne University Hospital (CHUV), Switzerland

The Future of Natus Medical

Natus Medical continues to be a trusted source for healthcare providers working to diagnose and treat conditions affecting the brain and nervous system effectively. By creating these advisory boards, Natus not only affirms its position as a leader in neurodiagnostics but also drinks in the wealth of knowledge from healthcare professionals worldwide. This collaborative spirit is bound to lead to groundbreaking solutions, improving patient outcomes and the quality of life for those they serve.

For comprehensive information about Natus and its ongoing commitments, visit natus.com.